GSK-3 is activated by the tyrosine kinase Pyk2 during LPA 1-mediated neurite retraction

Molecular Biology of the Cell

Volumn 17, Issue 4, 2006, Pages 1834-1844

  Sayas, C Laura ^a,b   Ariaens, Aafke ^a   Ponsioen, Bas ^a   Moolenaar, Wouter H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; CALCIUM ION; FOCAL ADHESION KINASE 2; GLYCOGEN SYNTHASE KINASE 3; GUANINE NUCLEOTIDE BINDING PROTEIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; MYOSIN ADENOSINE TRIPHOSPHATASE; TAU PROTEIN; TYROSINE; CALCIUM; LYSOPHOSPHOLIPID; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MOUSE; NEURITE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RNA INTERFERENCE; ANIMAL; DRUG ANTAGONISM; DRUG POTENTIATION; ENZYMOLOGY; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; CALCIUM; ENZYME ACTIVATION; FOCAL ADHESION KINASE 2; GLYCOGEN SYNTHASE KINASE 3; HYDROLYSIS; LYSOPHOSPHOLIPIDS; MICE; NEURITES; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHORYLATION; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID; TAU PROTEINS; TYROSINE;

EID: 33745374264     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E05-07-0688     Document Type: Article

References (71)

1. Andreev, J., Galisteo, M. L., Kranenburg, O., Logan, S. K., Chiu, E. S., Okigaki, M., Cary, L. A., Moolenaar, W. H., and Schlessinger, J. (2001). Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J. Biol. Chem. 276, 20130-20135.
2. Avraham, H., Park, S. Y., Schinkmann, K., and Avraham, S. (2000). RAFTK/Pyk2-mediated cellular signalling. Cell Signal. 12, 123-133.
3. Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., and Lee, C. M. (2000). Regulation and localization of tyrosirte216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. USA 97, 11074-11079.
4. Brummelkamp, T. R., Bernards, R., and Agami, R. (2002). Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247.
5. Chun, J., Goetzl, E. J., HIa, T., Igarashi, Y., Lynch, K. R., Moolenaar, W., Pyne, S., and Tigyi, G. (2002). International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 54, 265-269.
6. Cohen, P. and Goedert, M. (2004). GSK3 inhibitors: development and therapeutic potential. Nat. Rev. Drug Discov. 3, 479-487.
7. Cole, A., Frame, S., and Cohen, P. (2004). Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem. J. 377, 249-255.
8. Cross, D. A., Alessi, D. R., Cohen, P., Andjelkovich, M., and Hemmings, B. A. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
9. Dajani, R., Fraser, E., Roe, S. M., Young, N., Good, V., Dale, T. C., and Pearl, L. H. (2001). Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732.
10. Dikic, I., Tokiwa, G., Lev, S., Courtneidge, S. A., and Schlessinger, J. (1996). A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383, 547-550.
11. Doble, B. W. and Woodgett, J. R. (2003). GSK-3, tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186.
12. Drewes, G. (2004). MARKing tau for tangles and toxicity. Trends Biochem. Sci. 29, 548-555.
13. Eickholt, B. J., Walsh, F. S., and Doherry, P. (2002). An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J. Cell Biol. 157, 211-217.
14. Fan, G., Ballou, L. M., and Lin, R. Z. (2003). Phospholipase C-independent activation of glycogen synthase kinase-3beta and C-terminal Src kinase by Galphaq. J. Biol. Chem. 27, 52432-52436.
15. Fang, X., Yu, S., Tanyi, J. L., Lu, Y., Woodgett, J. R., and Mills, G. B. (2002). Convergence of multiple signaling cascades at glycogen synthase kinase 3, Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a PKC-dependent intracellular pathway. Mol. Cell. Biol. 22, 2099-2110.
16. Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Jr., Woodgett, J. R., and Mills, G. B. (2000). Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc. Natl. Acad. Sci. USA 97, 11960-11965.
17. Frame, S. and Cohen, P. (2001). GSK3 takes centre stage more than 20 years after its discovery. Biochem. J. 359, 1-16.
18. Fukushima, N., Ishii, I., Contos, J. J., Weiner, J. A., and Chun, J. (2001). Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 41, 507-534.
19. Fuortes, M., Melchior, M., Han, H., Lyon, G. J., and Nathan, C. (1999). Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF. J. Clin. Invest 104, 327-335.
20. Grimes, C. A. and Jope, R. S. (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65, 391-426.
21. Haglund, K., Ivankovic-Dikic, I., Shimokawa, N., Kruh, G. D., and Dikic, I. (2004). Recruitment of Pyk2 and CbI to lipid rafts mediates signals important for actin reorganization in growing neurites. J. Cell Sci. 117, 2557-2568.
22. Hanger, D. P., Hughes, K., Woodgett, J. R., Brion, J. P., and Anderton, B. H. (1992). Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62.
23. Hartigan, J. A. and Johnson, G. V. (1999). Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase Sbeta-dependent pathway. J. Biol. Chem. 274, 21395-21401.
24. Hartigan, J. A., Xiong, W. C., and Johnson, G. V. (2001). Glycogen synthase kinase Sbeta is tyrosine phosphorylated by PYK2. Biochem. Biophys. Res. Commun. 284, 485-489.
25. Henley, J. M. and Nishimune, A. (2001). CAKbeta/Pyk2 activates Src: another piece in the puzzle of LTP induction. Neuron 29, 312-314.
26. Hirose, M., Ishizaki, T., Watanabe, N., Uehata, M., Kranenburg, O., Moolenaar, W. H., Matsumura, F., Maekawa, M., Bito, H., and Narumiya, S. (1998). Molecular dissection of the Rho-associated protein kinase (p16ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J. Cell Biol. 141, 1625-1636.
27. Huang, Y. et al. (2001). CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron 29, 485-496.
28. Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., and Woodgett, J. R. (1993). Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803-808.
29. Ivankovic-Dikic, L, Gronroos, E., Blaukat, A., Earth, B. U., and Dikic, I. (2000). Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins. Nat. Cell Biol. 2, 574-581.
30. Jalink, K., Hengeveld, T., Mulder, S., Postma, F. R., Simon, M.F., Chap, H., van der Marel, G. A., van Boom, J. H., van Blitterswijk, W. J., and Moolenaar, W. H. (1995). Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis. Biochem. J. 307(Pt 2), 609-616.
31. Jalink, K., van Corven, E. J., Hengeveld, T., Morii, N., Narumiya, S., and Moolenaar, W. H. (1994). Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein. Rho. J. Cell Biol. 126, 801-810.
32. Jalink, K., van Corven, E. J., and Moolenaar, W. H. (1990). Lysophosphatidic acid, but not phosphatidic acid, is a potent Ca2(+)-mobilizing stimulus for fibroblasts. Evidence for an extracellular site of action. J. Biol. Chem. 265, 12232-12239.
33. Jiang, H., Guo, W., Liang, X., and Rao, Y. (2005). Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 120, 123-135.
34. Jope, R. S. and Johnson, G. V. (2004). The glamour and gloom of glycogen synthase kinase-3. Trends Biochem. Sci. 29, 95-102.
35. Kim, L., Liu, J., and Kimmel, A. R. (1999). The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification. Cell 99, 399-408.
36. Kingsbury, M. A., Rehen, S. K., Contos, J. J., Higgins, C. M., and Chun, J. (2003). Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat. Neurosci. 6, 1292-1299.
37. Kranenburg, O., Poland, M., van Horck, F. P., Drechsel, D., Hall, A., and Moolenaar, W. H. (1999). Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction. Mol. Biol. Cell 10, 1851-1857.
38. Leroy, K. and Brion, J. P. (1999). Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J. Chem. Neuroanat. 16, 279-293.
39. Lesort, M., Jope, R. S., and Johnson, G. V. (1999). Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J. Neurochem. 72, 576-584.
40. Lev, S., Moreno, H., Martinez, R., Canoll, P., Peles, E., Musacchio, J. M., Plowman, G. D., Rudy, B., and Schlessinger, J. (1995). Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 376, 737-745.
41. Levitzki, A. and Gilon, C. (1991). Tyrphostins as molecular tools and potential antiproliferative drugs. Trends Pharmacol. Sci. 12, 171-174.
42. Loeser, R. F., Forsyth, C. B., Samarel, A. M., and Im, H. J. (2003). Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a PKC-dependent pathway. J. Biol. Chem. 278, 24577-24585.
43. Menegon, A., Burgaya, F., Baudot, P., Dunlap, D. D., Girault, J. A., and Valtorta, F. (1999). FAK+ and PYK2/CAKbeta, two related tyrosine kinases highly expressed in the central nervous system: similarities and differences in the expression pattern. Eur. J. Neurosci. 11, 3777-3788.
44. Moolenaar, W. H., van Meeteren, L. A., and Giepmans, B. N. (2004). The ins and outs of lysophosphatidic acid signaling. Bioessays 26, 870-881.
45. Mukai, F., Ishiguro, K., Sano, Y., and Fujita, S. C. (2002). Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta. J. Neurochem. 81, 1073-1083.
46. Mulder, J., Ariaens, A., van den Boomen, D., and Moolenaar, W. H. (2004). plloRip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis. Mol. Biol. Cell 15, 5516-5527.
47. Noguchi, K., Ishii, S., and Shimizu, T. (2003). Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278, 25600-25606.
48. Okigaki, M., Davis, C., Falasca, M., Harroch, S., Felsenfeld, D. P., Sheetz, M. P., and Schlessinger, J. (2003). Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proc. Natl. Acad. Sci. USA 100, 10740-10745.
49. Park, S. Y., Avraham, H., and Avraham, S. (2000). Characterization of the tyrosine kinases RAFTK/Pyk2 and FAK in nerve growth factor-induced neuronal differentiation. J. Biol. Chem. 275, 19768-19777.
50. Perez, M., Rojo, A. L, Wandosell, F., Diaz-Nido, J., and Avila, J. (2003). Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase. Biochem. J. 372, 129-136.
51. Postma, F. R., Jalink, K., Hengeveld, T., Offermanns, S., and Moolenaar, W. H. (2001). Galpha(13) mediates activation of a depolarizing chloride current that accompanies RhoA activation in both neuronal and nonneuronal cells. Curr. Biol. 11, 121-124.
52. Sayas, C. L., Avila, J., and Wandosell, F. (2002a). Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3. Biochim. Biophys. Acta 1582, 144-153.
53. Sayas, C. L., Avila, J., and Wandosell, F. (2002b). Glycogen synthase kinase-3 is activated in neuronal cells by Galphal2 and GalphalS by Rho-independent and Rho-dependent mechanisms. J. Neurosci. 22, 6863-6875.
54. Sayas, C. L., Moreno-Flores, M. T., Avila, J., and Wandosell, F. (1999). The neurite retraction induced by lysophosphatidic acid increases Alzheimer's disease-like Tau phosphorylation. J. Biol. Chem. 274, 37046-37052.
55. Schaffer, B., Wiedau-Pazos, M., and Geschwind, D. H. (2003). Gene structure and alternative splicing of glycogen synthase kinase 3 beta (GSK-3beta) in neural and non-neural tissues. Gene 302, 73-81.
56. Takahashi, M., Tomizawa, K., Kato, R., Sato, K., Uchida, T., Fujita, S. C., and Imahori, K. (1994). Localization and developmental changes of tau protein kinase I/glycogen synthase kinase-3 beta in rat brain. J. Neurochem. 63, 245-255.
57. Tian, D., Litvak, V., and Lev, S. (2000). Cerebral ischemia and seizures induce tyrosine phosphorylation of PYK2 in neurons and microglial cells. J. Neurosci. 20, 6478-6487.
58. Tokuoka, H., Yoshida, T., Matsuda, N., and Mishina, M. (2002). Regulation by glycogen synthase kinase-3beta of the arborization field and maturation of retinotectal projection in zebrafish. J. Neurosci. 22, 10324-10332.
59. Trivedi, N., Marsh, P., Goold, R. G., Wood-Kaczmar, A., and Gordon-Weeks, P. R. (2005). Glycogen synthase kinase-Sbeta phosphorylation of MAP1B at Serl260 and Thrl265 is spatially restricted to growing axons. J. Cell Sci. 118, 993-1005.
60. van der Wal, J., Habets, R., Varnai, P., Balla, T., and Jalink, K. (2001). Monitoring agonist-induced phospholipase C activation in live cells by fluorescence resonance energy transfer. J. Biol. Chem. 276, 15337-15344.
61. Van Leeuwen, F. N., Olivo, C., Grivell, S., Giepmans, B. N., Collard, J. G., and Moolenaar, W. H. (2003). Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiaml. J. Biol. Chem. 278, 400-406.
62. Wagner, U., Utton, M., Gallo, J. M., and Miller, C. C. (1996). Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J. Cell Sci. 109(Pt 6), 1537-1543.
63. Wang, Q. M., Fiol, C. J., DePaoli-Roach, A. A., and Roach, P. J. (1994). Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J. Biol. Chem. 269, 14566-14574.
64. Welsh, G. I., Patel, J. C., and Proud, C. G. (1997). Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts. Anal. Biochem. 244, 16-21.
65. Woodgett, J. R. (1990). Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J. 9, 2431-2438.
66. Woodring, P. J., Litwack, E. D., O'Leary, D. D., Lucero, G. R., Wang, J. Y., and Hunter, T. (2002). Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension. J. Cell Biol. 256, 879-892.
67. Wu, S. S., Chiu, T., and Rozengurt, E. (2002). ANG II and LPA induce Pyk2 tyrosine phosphorylation in intestinal epithelial cells: role of Ca2+, PKC, and Rho kinase. Am. J. Physiol. Cell Physiol. 282, C1432-C1444.
68. Yoshimura, T., Kawano, Y., Arimura, N., Kawabata, S., Kikuchi, A., and Kaibuchi, K. (2005). GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120, 137-149.
69. Yu, H. et al. (1996). Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation. J. Biol. Chem. 271, 29993-29998.
70. Zhou, F. Q. and Snider, W. D. (2005). Cell biology. GSK-3beta and microtubule assembly in axons. Science 308, 211-214.
71. Zhou, F. Q., Zhou, J., Dedhar, S., Wu, Y. H., and Snider, W. D. (2004). NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 42, 897-912.